Exact Mass: 598.1643
Exact Mass Matches: 598.1643
Found 216 metabolites which its exact mass value is equals to given mass value 598.1643
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N-(Hydrocinchonidin-8-yl)-4-azido-2-hydroxybenzamide
10-Acetoxyoleuropein
10-Acetoxyoleuropein is found in herbs and spices. 10-Acetoxyoleuropein is a constituent of osmanthus leaves (Osmanthus fragrans). Constituent of osmanthus leaves (Osmanthus fragrans). 10-Acetoxyoleuropein is found in herbs and spices.
Losartan N2-glucuronide
Losartan N2-glucuronide is only found in individuals that have used or taken Losartan. Losartan N2-glucuronide is a metabolite of Losartan. Losartan n2-glucuronide belongs to the family of Pyranoid Amino Acids and Derivatives. These are compounds containing a (hydro)pyran ring bearing unprotected amino and carboxylic acid functionalities.
C.I. Pigment Red 149
C.I. Pigment Red 149 is a fda approved colourant for food contact polymer FDA approved colourant for food contact polymers
7-N-(2-((2-(gamma-L-Glutamylamino)ethyl)dithio)ethyl)mitomycin C
Leucopelargonidin 3-O-alpha-L-rhamno-beta-D-glucopyranoside
Leucopelargonidin 3-o-alpha-l-rhamno-beta-d-glucopyranoside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Leucopelargonidin 3-o-alpha-l-rhamno-beta-d-glucopyranoside can be found in loquat, which makes leucopelargonidin 3-o-alpha-l-rhamno-beta-d-glucopyranoside a potential biomarker for the consumption of this food product.
3-Hydroxy-2-methyl-4-[(7-oxo-7H-furo[3,2-g]chromen-4-yl)oxy]-2-butanyl 6-O-[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-β-D-glucopyranoside
5,7-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]oxymethyl]oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylic acid
3,4-Dihydroxyphenylethanol-8-O-[(5-O-vanilloyl)-??-D-apiofuranosyl(1鈥樏傗垎2)]-??-D-glucopyranoside
3,4-dihydro-10-hydroxy-7-methoxy-3-(R)-methyl-1H-3,4-dihydronaphtho-<2,3c>-pyran-1-one-9-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|3,4-dihydro-10-hydroxy-7-methoxy-3-(R)-methyl-1H-3,4-dihydronaphtho-[2,3c]-pyran-1-one-9-O-beta-D-glucopyranosyl-(1->6)-glucopyranoside
9-[(2R)-3-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-2-hydroxy-3-methylbutoxy]furo[3,2-g]chromen-7-one
3,4,4,7-Tetramethoxy-5,5-dihydroxy-8,3-biflavanone
(2S)-6,8-dimethyl-5,7,2,5-tetrahydroflavanone 7-O-(6-O-p-hydroxybenzoyl)-beta-D-glucopyranoside|myrciacitrin V
3-Methoxy-5,7-dihydroxy-8-[2,4-dihydroxy-3-[3-(4-hydroxyphenyl)propionyl]-5-methyl-6-methoxybenzyl]flavone
2?-beta-D-glucopyranosyloxybenzyl 6-alpha-L-rhamnopyranosyloxy-2-hydroxy-3-methoxybenzoate
2?-beta-D-glucopyranosyloxybenzyl 6-alpha-L-rhamnopyranosyloxy-3-hydroxy-2-methoxybenzoate
1-O-[beta?D-xylopyranosyl-(1?6)-beta?D-glucopyranosyl]-3,8-dihydroxy-4,5-dimethoxyxanthone
3,3,4,5,9,10-hexahydroxy-12-methylchroman[2,3-h]flavone 3-O-beta-D-glucopyranoside|lactucasativoside A
3-O-[beta-D-xylopyranosyl-(1?6)-beta-D-glucopyranosyl]-1,8-dihydroxy-4,5-dimethoxyxanthone|kouitchenside F
3-methoxy-7-O-beta-(6-galloylglucopyranoside)kaempferol
1-(2,4-bis-beta-D-glucopyranosyloxy-6-hydroxy-phenyl)-3-(4-hydroxy-phenyl)-propan-1-one|1-(2,4-Bis-beta-D-lucopyranosyloxy-6-hydroxy-phenyl)-3-(4-hydroxy-phenyl)-propan-1-on|phloretin-2,4-di-O-beta-D-glucopyranoside
sec-[O-beta-D-apiofuranosyl-(1->6)-O-beta-D-glucopyranosyl]-oxypeucedanin hydrate
beta-D-glucopyranosyl (6->1)-beta-D-glucopyranosyl-4-(4-ethylphenyl)gallate|mimusopstannin
(1R*,3aS*,4E,6Z,8S*,8aR*,9S*,11R*,12R*,12aS*,13S*,13aS*)-5-(chloromethyl)-1,3a,8,8a,9,10,11,12a,13,13a-decahydro-13a-hydroxy-1,8a-dimethyl-2-oxo-2H-spiro[benzo[4,5]cyclodeca[1,2-b]furan-12,2-oxirane]-8,9,11,13-tetrayl tetraacetate|frajunolide C|rel-(1R,2S,7S,8S,9S,10S,11R,12R,14S,17R)-2,9,12,14-tetraacetoxy-16-chloro-11,20-epoxy-8-hydroxybriara-3,5-dien-18,7-olide
[4-(5-sulfanylidenedithiol-3-yl)phenyl] 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]hept-5-enoate
{3,4,5-triacetyloxy-6-[3-(4-methoxyphenyl)-4-oxochromen-6-yloxy]-2H-3,4,5,6-te trahydropyran-2-yl}methyl acetate
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.356 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.355
4-[3-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-2-hydroxy-3-methylbutoxy]furo[3,2-g]chromen-7-one
4-[3-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-2-hydroxy-3-methylbutoxy]furo[3,2-g]chromen-7-one
[(2S,3R,4S,5S,6R)-4,5-dihydroxy-2-[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxy-6-[[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetyl]oxymethyl]oxan-3-yl] 2-phenylacetate
4-[3-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-2-hydroxy-3-methylbutoxy]furo[3,2-g]chromen-7-one [IIN-based: Match]
4-[3-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-2-hydroxy-3-methylbutoxy]furo[3,2-g]chromen-7-one [IIN-based on: CCMSLIB00000848662]
CP-532623
CONFIDENCE standard compound; INTERNAL_ID 689; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5617; ORIGINAL_PRECURSOR_SCAN_NO 5613 CONFIDENCE standard compound; INTERNAL_ID 689; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5639; ORIGINAL_PRECURSOR_SCAN_NO 5637 CONFIDENCE standard compound; INTERNAL_ID 689; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5599; ORIGINAL_PRECURSOR_SCAN_NO 5597 CONFIDENCE standard compound; INTERNAL_ID 689; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5626; ORIGINAL_PRECURSOR_SCAN_NO 5624 CONFIDENCE standard compound; INTERNAL_ID 689; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5625; ORIGINAL_PRECURSOR_SCAN_NO 5622 CONFIDENCE standard compound; INTERNAL_ID 689; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5627; ORIGINAL_PRECURSOR_SCAN_NO 5624
5,7-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]oxymethyl]oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylic acid_major
Losartan Metabolite (b-D-Glucopyranuronic acid, 1-[5-[4-[[2-butyl-4-chloro-5-(hydroxymethyl)-1H-imi
ACS 67
Losartan N2-glucuronide
Pigment Red 149
10-Acetoxyoleuropein
1,3-bis(2,4,6-trimethylphenyl)imidazolidin-2-ide,dichloro(3-pyridin-2-ylpropylidene)ruthenium
Heraclenol 3-O-[beta-D-apiofuranosyl-(1-6)-beta-D-glucopyranoside]
N,N-BIS(2,6-DIMETHYLPHENYL)PERYLENE-3,4,9,10-TETRACARBOXYLIC DIIMIDE
2,9-bis(2-phenylethyl)anthra[2,1,9-def:6,5,10-def]diisoquinoline-1,3,8,10(2H,9H)-tetrone
N-[(1S)-1-[[(6S)-6-[5-(7-BROMO-9,9-DIFLUORO-9H-FLUOREN-2-YL)-1H-IMIDAZOL-2-YL]-5-AZASPIRO[2.4]HEPT-5-YL]CARBONYL]-2-METHYLPROPYL]CARBAMIC ACID METHYL ESTER
N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-1-methyl-2,3-dioxopiperidine-4-carboxamide
Benzenesulfonic acid, hexadecyl(sulfophenoxy)-, disodium salt
(R)-(-)-2,2-Bis(p-toluenesulfonyloxy)-1,1-binaphthalene
1,2-BIS(DICYCLOHEXYLPHOSPHINO)ETHANE]PALLADIUM(II) CHLORIDE
(2R,4S)-4-(Acetyl(3,5-bis(trifluoromethyl)benzyl)amino)-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid isopropyl ester
3-({5-Benzyl-6-hydroxy-2,4-bis-(4-hydroxy-benzyl)-3-oxo-[1,2,4]-triazepane-1-sulfonyl)-benzonitrile
Leucopelargonidin 3-O-alpha-L-rhamno-beta-D-glucopyranoside
Myrciacitrin V
A flavanone glycoside that is (2S)-flavanone substituted by hydroxy groups at positions 5, 2 and 5, methyl groups at positions 6 and 8 and a (6-O-p-hydroxybenzoyl)-beta-D-glucopyranosyloxy residue at position 7. Isolated from the leaves of Myrcia multiflora, it exhibits inhibitory activity against aldose reductase.
[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-[(2R,4R)-4-(1-benzothiophen-3-yl)-2-[[4-(hydroxymethyl)phenyl]methoxy]-3,4-dihydro-2H-pyran-6-yl]methanone
[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-[(2S,4S)-4-(1-benzothiophen-3-yl)-2-[[4-(hydroxymethyl)phenyl]methoxy]-3,4-dihydro-2H-pyran-6-yl]methanone
Benzoic acid [3,4-dibenzoyloxy-5-(2,4-dioxo-5-propan-2-yl-1-pyrimidinyl)-2-oxolanyl]methyl ester
4-[3-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-2-hydroxy-3-methylbutoxy]furo[3,2-g]chromen-7-one
IACS-010759 (hydrochloride)
IACS-010759 hydrochlorideis an orally active, potent mitochondrial complex I of oxidative phosphorylation (OXPHOS) inhibitor. IACS-010759 hydrochlorideinhibits proliferation and induces apoptosis in models of brain cancer and acute myeloid leukemia (AML) reliant on OXPHOS. IACS-010759 hydrochloride has the potential for relapsed/refractory AML and solid tumors research[1][2].
methyl 2-[11,24-dihydroxy-18-(2-methoxy-2-oxoethyl)-7,20-dimethyl-9,22-dioxo-6,19-dioxaheptacyclo[13.11.1.1²,¹⁰.0³,⁸.0¹⁶,²¹.0²³,²⁷.0¹⁴,²⁸]octacosa-1,3(8),10(28),11,13,15(27),16(21),23,25-nonaen-5-yl]acetate
(1'r,2r,2's,3's,7's,8'r,9'r,10'r,11'r,13's,14'r,17'r)-2',7',9'-tris(acetyloxy)-13'-chloro-8',17'-dimethyl-12'-methylidene-16'-oxo-15',18'-dioxaspiro[oxirane-2,4'-tetracyclo[9.6.1.0¹,¹⁴.0³,⁸]octadecan]-10'-yl acetate
4,5-bis(acetyloxy)-2-methoxy-3-[3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]benzoic acid
methyl (4s,5e,6s)-5-[2-(acetyloxy)ethylidene]-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,6-dihydropyran-3-carboxylate
(6-{[2-(2,5-dihydroxyphenyl)-5-hydroxy-6,8-dimethyl-4-oxo-2,3-dihydro-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 4-hydroxybenzoate
3,4,5',6',9,10'-hexamethoxy-[1,1'-biphenanthrene]-2,2',7,7'-tetrol
4-{[4-(acetyloxy)-2,9,10-trihydroxy-8-(5-hydroxy-6-methyloxan-2-yl)-2-methyl-1,5-dioxo-3h,4h-benzo[b]fluoren-3-yl]oxy}-4-oxobutanoic acid
(1's,2r,2's,3'r,4'r,7'r,8's,10'e,12's,13'r,14's,16's)-2',14',16'-tris(acetyloxy)-8'-chloro-3'-hydroxy-4',13'-dimethyl-9'-methylidene-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecan]-10'-en-12'-yl acetate
(3r)-10-hydroxy-7-methoxy-3-methyl-9-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-3h,4h-naphtho[2,3-c]pyran-1-one
5-{8-chloro-12-hydroxy-10,13,14-trimethyl-9,16-dioxo-4,11,15-trioxatetracyclo[8.7.0.0²,⁷.0¹²,¹⁷]heptadeca-2,5,7-trien-5-yl}-3-methylpent-4-en-2-yl 2-methoxy-2-phenylacetate
13,21-dihydroxy-5,7,29-trimethoxy-13,23-dimethyl-16-oxahexacyclo[15.12.0.0²,¹¹.0⁴,⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2(11),4,6,8,17,20,22,24,27-decaene-3,10,15,19,26-pentone
2,6,7-tris(acetyloxy)-13-chloro-11-hydroxy-8,17-dimethyl-4,12-dimethylidene-16-oxo-15,18-dioxatetracyclo[9.6.1.0¹,¹⁴.0³,⁸]octadecan-9-yl acetate
1,8-dihydroxy-5,6-dimethoxy-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}xanthen-9-one
2',14',16'-tris(acetyloxy)-8'-chloro-3'-hydroxy-4',13'-dimethyl-9'-methylidene-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecan]-10'-en-12'-yl acetate
2',14',15'-tris(acetyloxy)-8'-chloro-3'-hydroxy-4',13'-dimethyl-9'-methylidene-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecan]-10'-en-12'-yl acetate
(2r)-2-[(2s,3s)-3-(3,5-dihydroxyphenyl)-6-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-5-yl]-5,7-dihydroxy-8-[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]-2,3-dihydro-1-benzopyran-4-one
methyl (1s,4ar,6s,7r,7as)-4a,7-dihydroxy-6-{[(2e)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoyl]oxy}-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate
13-o-[β-d-apiofuranosyl(1→6)-β-d-gluco-pyranosyl]-(12r)-heraclenol
{"Ingredient_id": "HBIN001272","Ingredient_name": "13-o-[\u03b2-d-apiofuranosyl(1\u21926)-\u03b2-d-gluco-pyranosyl]-(12r)-heraclenol","Alias": "NA","Ingredient_formula": "C27H34O15","Ingredient_Smile": "CC(C)(C(COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2)O)OC4C(C(C(C(O4)COC5C(C(CO5)(CO)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1510","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3,4-dihydroxyphenylethanol-8-o-[(5-o-vanilloyl)-β-d-apiofuranosyl(1→2)]-β-d-glucopyranoside
{"Ingredient_id": "HBIN007415","Ingredient_name": "3,4-dihydroxyphenylethanol-8-o-[(5-o-vanilloyl)-\u03b2-d-apiofuranosyl(1\u21922)]-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C27H34O15","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6079","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}